CAR-T Meeting 2024 | ASCERTAIN consortium: aiming to improve affordability and accessibility to novel health technologies
In this video, Frederick Thielen, PhD, Erasmus University Rotterdam, Rotterdam, Netherlands, introduces the ASCERTAIN research consortium, briefly discussing the initiative’s main aims and three-pillared approach. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research funding: Celgene B.V., NICE (UK National Institute for Health and Care Excellence), CADTH (Canadian Agency for Drugs and Technologies in Health), the Dutch Ministry of Health, Welfare and Sport, the Dutch Health Care Institute, and the European Haematology Association; Consultancy: AstraZeneca, Optimax Access, Dark Peak Analytics. Dr Thielen teaches Statistical Programming & Data Science in R, at TriData, an institute for applied statistics and data analysis.
